Your browser doesn't support javascript.
loading
First-in-human phase 1 trial of hemoglobin vesicles as artificial red blood cells developed for use as a transfusion alternative.
Azuma, Hiroshi; Amano, Toraji; Kamiyama, Naoya; Takehara, Naofumi; Jingu, Maki; Takagi, Harumi; Sugita, Osamu; Kobayashi, Naoko; Kure, Tomoko; Shimizu, Taro; Ishida, Tatsuhiro; Matsumoto, Masanori; Sakai, Hiromi.
Afiliación
  • Azuma H; Department of Pediatrics, Asahikawa Medical University, Asahikawa, Japan.
  • Amano T; Clinical Research and Medical Innovation Center, Hokkaido University Hospital, Sapporo, Japan.
  • Kamiyama N; Clinical Research Support Center, Asahikawa Medical University, Asahikawa, Japan.
  • Takehara N; Clinical Research Support Center, Asahikawa Medical University, Asahikawa, Japan.
  • Jingu M; Clinical Research and Medical Innovation Center, Hokkaido University Hospital, Sapporo, Japan.
  • Takagi H; Clinical Research and Medical Innovation Center, Hokkaido University Hospital, Sapporo, Japan.
  • Sugita O; Clinical Research and Medical Innovation Center, Hokkaido University Hospital, Sapporo, Japan.
  • Kobayashi N; Department of Chemistry, Nara Medical University, Kashihara, Japan.
  • Kure T; Department of Chemistry, Nara Medical University, Kashihara, Japan.
  • Shimizu T; Department of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University, Tokushima, Japan.
  • Ishida T; Department of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University, Tokushima, Japan.
  • Matsumoto M; Department of Blood Transfusion Medicine, Nara Medical University, Kashihara, Japan.
  • Sakai H; Cell Processing Center, Nara Medical University Hospital, Kashihara, Japan.
Blood Adv ; 6(21): 5711-5715, 2022 11 08.
Article en En | MEDLINE | ID: mdl-35939788

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sustitutos Sanguíneos Límite: Humans Idioma: En Revista: Blood Adv Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sustitutos Sanguíneos Límite: Humans Idioma: En Revista: Blood Adv Año: 2022 Tipo del documento: Article País de afiliación: Japón
...